Status:
COMPLETED
Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment
Lead Sponsor:
Bayer
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment
Eligibility Criteria
Inclusion
- Patients over 18 years of age
- Arterial hypertension (SBP \< 160 mmHg and DBP \< 100 mmHg)
- Patients, who do not tolerate ACE inhibitors (must be documented in the official ambulant documentation)
- Inclusion criteria for the control arm (treated by ACEi):
- Patients over 18 years of age
- Arterial hypertension (SBP \< 160 mmHg and DBP \< 100 mmHg)
- Patients, who tolerate ACEi treatment
Exclusion
- Cholestasis, severe hepatic insufficiency
- Allergy to telmisartan
- Gravidity or lactation
- Exclusion criteria for the arm of patient treated by ACEi:
- Cholestasis, severe hepatic insufficiency
- Allergy to ACEi
- Gravidity or lactation
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
3114 Patients enrolled
Trial Details
Trial ID
NCT00932867
Start Date
December 1 2007
End Date
August 1 2009
Last Update
April 20 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Romania
2
Many Location, Slovakia